NCCS’ novel approach improves success rate of bone marrow transplantation – The Hindu
The Hindu |
NCCS’ novel approach improves success rate of bone marrow transplantation
The Hindu Currently, haematopoietic stem cells (HSCs) taken from older donors for bone marrow transplantation have lower efficiency and capacity to engraft in recipients thus limiting their usefulness. But all this is set to change. Researchers from Pune’s … |
Medical Xpress |
Study prompts new ideas on cancers’ origins
Medical Xpress Graduate student Megan Radyk and Jason Mills, M.D., Ph.D., led a study revealing that although many cancer therapies target rapidly dividing stem cells, mature cells also seem to play a key role in initiating cancer, at least in forming precancerous … |
Digital Journal |
Gene therapy and possible cure for hemophilia A
Digital Journal This is the therapeutic delivery of nucleic acid into a patient’s cells as a drug to treat disease. Gene therapy is a way to fix a genetic problem at its source, involving replacing a mutated gene that causes disease with a healthy copy of the gene; or … Trial gene therapy was a big success for Billericay dad Jake OmerEcho Haemophilia A trial results ‘mind-blowing’Daily Times ‘Mind-blowing’ trial could transform treatment for haemophilia sufferersBT Sport Brinkwire (press release) all 7 news articles » |
BioWorld Online |
Tigenix gets EMA nod for off-the-shelf stem cell therapy in Crohn’s disease
BioWorld Online LONDON – Eight years on from securing the first EMA approval for an autologous cell therapy, Tigenix NV has done it again, getting the nod for the first allogeneic adipose-derived stem cell therapy, Alofisel (Cx601, darvadstrocel), in the treatment of … |
|
Bluebird Bio, TC BioPharm Partner to Develop Gamma Delta CAR T-cell Therapy Candidates
Immuno-Oncology News Bluebird bio and TC BioPharm recently announced a new partnership to develop gamma delta CAR T-cell product candidates for the treatment of cancer. The collaboration and licensing agreement were established to advance TC BioPharm’s CAR-engineered gamma … |